Andrew Callos

EVP, Chief Commercial Officer

Andrew Callos (EVP, Chief Commercial Officer) filed 18 Form 4 reports in the trailing twelve months (0 purchases, 18 sales), most often in Cytokinetics, Incorporated (CYTK). The largest single filing was $3.5M of CYTK (52,486 sh × $65.95, as filed), executed Dec 5 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 18 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$15.7M

shares × price, as filed

Last traded

Aug 31

Filed Aug 31

Median ADV $207.8M across their filed names

Open performance→

Volume by month

Buys $0 Sells $18.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 18 filings

Sector per market data · by filing · past 12 months

Most traded names

CYTK

Cytokinetics, Incorporated CYTK · 0 buys · 25 sells 25 filings

Recent filings

CYTKSALE Cytokinetics, Incorporated View filing → $237K
3,639 sh × $65.00
Exec Mar 31
Filed Mar 31 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $120K
1,930 sh × $62.07
Exec Mar 18
Filed Mar 18 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $531K
8,542 sh across 2 lots
Exec Mar 17
Filed Mar 18 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $104K
1,709 sh × $61.03
Exec Mar 16
Filed Mar 16 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $157K
2,582 sh × $60.72
Exec Mar 9
Filed Mar 10 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $1.6M
26,000 sh across 2 lots
Exec Mar 5
Filed Mar 5 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $929K
15,000 sh × $61.93
Exec Feb 5
Filed Feb 5 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $904K
15,000 sh × $60.28
Exec Jan 5
Filed Jan 5 · 5:30 PM ET More filings →